Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1988-09-21
1992-06-30
Kepplinger, Esther L.
Drug, bio-affecting and body treating compositions
Lymphokine
424 89, 424 90, 424 91, 424 92, 514 2, 514 8, 514 10, 514 21, 530403, 530402, 530404, 530405, 530406, 530807, 530810, 530813, A61K 39395
Patent
active
051261316
ABSTRACT:
Undesired immune responses are suppressed by administering a nonimmunogenic material which comprises one or more haptens or epitopes corresponding to the antigen which causes the undesired immune response, the number and spacing of the haptens or epitopes being insufficient to trigger an immune response but sufficient to inhibit it. Also disclosed is an improved vaccine from which low molecular weight suppressive polymer has been removed.
REFERENCES:
patent: 3794630 (1974-02-01), Mullan
patent: 3869546 (1975-03-01), Lund
patent: 3919411 (1975-11-01), Glass
patent: 4140679 (1979-02-01), Malley
patent: 4191668 (1980-03-01), Katz
patent: 4253995 (1981-03-01), Katz
patent: 4261973 (1981-04-01), Lee
patent: 4310514 (1982-01-01), Durette
Desaynard, C. et al, Eur. J. Immunol, vol. 5, pp. 541-545 (1975).
Lui, F. et al, Proc. Natl. Acad. Sci, U.S.A., vol. 76(3), pp. 1430-1434 (1979).
Peacock, J. S. et al., J. Immunology, vol. 127(3) pp. 900-906 (1981).
Immunological Reviews, vol. 50, Unresponsivenes To Haptenated Self Structures, Copenhagen (1980).
Immunological Reviews, vol. 43, Mechanism of B Lymphocyte Tolerance, Copenhagen (1979).
Brown, H. M. et al., Acta Allergolagica, vol. 31, pp. 22-34 (1976).
Feldmann, M., J. Exper. Med, vol. 135, pp. 735-753 (1972).
Feldmann, M. et al. Extracellular Matrix Influence on Gene Expression, Academic Press, London (1975).
Perelson, A. A. et al. in Paradoxes in Immunology, Hoffman, G. W. et al. eds, CRC Press, Boca Raton, Fla. (1986), pp. 199-214.
Dintzis et al, "Molecular Determinants of Immunogenicity: The Immunon Model of Immune Response", Proc. Natl. Acad. Sci. U.S.A., vol. 73, No. 10, pp. 3671-3675, Oct. 1976.
"Specific Cellular Stimulation in the Primary Immune Response: A Quantized Model" by B. Vogelstein et al, Proc. Natl. Acad. Sci, U.S.A. vol. 79, pp. 395-399, Jan. 1982.
"Specific Cellular Stimulation in the Primary Immune Response: Experimental Test of a Quantized Model" by R. Z. Dintzis et al, Proc. Natl. Acad. Sci, U.S.A., vol. 79, pp. 884-888, Feb. 1982.
"Studies on the Immunogenicity and Tolerogenicity of T-Independent Antigens", by Renee Z. Dintzis et al, The Journal of Immunology, vol. 131, No. 5, Nov. 1983.
Chiorazzi et al, Proc. Natl. Acad. Sci. U.S.A., vol. 73, No. 6, pp. 2091-2095, Jun. 1976.
Dintzis Howard M.
Dintzis Renee Z.
Kepplinger Esther L.
Kushan Jeff
The Johns Hopkins University
LandOfFree
Therapeutic suppression of specific immune responses by administ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic suppression of specific immune responses by administ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic suppression of specific immune responses by administ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1862467